Aficamten reduces symptoms in obstructive hypertrophic cardiomyopathy

被引：0
|
作者：
Lim, Gregory B.
机构：
[1] Nature Reviews Cardiology,
来源：
NATURE REVIEWS CARDIOLOGY | 2024年 / 21卷 / 07期
关键词：
D O I：
10.1038/s41569-024-01044-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Data from the SEQUOIA-HCM trial show that aficamten, a cardiac myosin inhibitor, increases exercise capacity and improves quality of life in patients with symptomatic obstructive hypertrophic cardiomyopathy.
引用
收藏
页码：437 / 437
页数：1
相关论文
共 50 条
  • [1] Aficamten for Obstructive Hypertrophic Cardiomyopathy Reply
    Maron, Martin S.
    Coats, Caroline J.
    Jacoby, Daniel L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (07): : 665 - 666
  • [2] Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
    Maron, Martin S.
    Masri, Ahmad
    Nassif, Michael E.
    Barriales-Villa, Roberto
    Arad, Michael
    Cardim, Nuno
    Choudhury, Lubna
    Claggett, Brian
    Coats, Caroline J.
    Duengen, Hans-Dirk
    Garcia-Pavia, Pablo
    Hagege, Albert A.
    Januzzi, James L.
    Lee, Matthew M. Y.
    Lewis, Gregory D.
    Ma, Chang-Sheng
    Michels, Michelle
    Olivotto, Iacopo
    Oreziak, Artur
    Owens, Anjali T.
    Spertus, John A.
    Solomon, Scott D.
    Tfelt-Hansen, Jacob
    van Sinttruije, Marion
    Veselka, Josef
    Watkins, Hugh
    Jacoby, Daniel L.
    Heitner, Stephen B.
    Kupfer, Stuart
    Malik, Fady I.
    Meng, Lisa
    Wohltman, Amy
    Abraham, Theodore P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, : 1849 - 1861
  • [3] Aficamten vs Metoprolol for Obstructive Hypertrophic Cardiomyopathy
    Garcia-Pavia, Pablo
    Bilen, Ozlem
    Burroughs, Melissa
    Costabel, Juan Pablo
    Correia, Edileide de Barros
    Dybro, Anne M.
    Elliott, Perry
    Lakdawala, Neal K.
    Mann, Amy
    Nair, Ajith
    Nassif, Michael E.
    Poulsen, Steen H.
    Reant, Patricia
    Schulze, P. Christian
    Wang, Andrew
    Berhane, Indrias
    Heitner, Stephen B.
    Jacoby, Daniel L.
    Kupfer, Stuart
    Malik, Fady I.
    Meng, Lisa
    Sohn, Regina
    Wohltman, Amy
    Fifer, Michael A.
    JACC-HEART FAILURE, 2025, 13 (02) : 346 - 357
  • [4] Aficamten: A Breakthrough Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy
    Sneha Annie Sebastian
    Inderbir Padda
    Eric J. Lehr
    Gurpreet Johal
    American Journal of Cardiovascular Drugs, 2023, 23 : 519 - 532
  • [5] Aficamten: A Breakthrough Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy
    Sebastian, Sneha Annie
    Padda, Inderbir
    Lehr, Eric J. J.
    Johal, Gurpreet
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2023, 23 (05) : 519 - 532
  • [6] Aficamten in patients with obstructive hypertrophic cardiomyopathy: an integrated safety analysis
    Masri, A.
    Barriales-Villa, R.
    Elliott, P.
    Nassif, M. E.
    Owens, A. T.
    Oreziak, A.
    Tower-Rader, A.
    Chiu, M.
    Heitner, S. B.
    Kupfer, S.
    Malik, F., I
    Melloni, C.
    Meng, L.
    Wohltman, A.
    Saberi, S.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [7] Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy
    Maron, Martin S.
    Masri, Ahmad
    Nassif, Michael E.
    Barriales-Villa, Roberto
    Abraham, Theodore P.
    Arad, Michael
    Cardim, Nuno
    Choudhury, Lubna
    Claggett, Brian
    Coats, Caroline J.
    Dungen, Hans-Dirk
    Garcia-Pavia, Pablo
    Hagege, Albert A.
    Januzzi, James L.
    Kulac, Ian
    Lee, Matthew M. Y.
    Lewis, Gregory D.
    Ma, Chang-Sheng
    Michels, Michelle
    Oreziak, Artur
    Owens, Anjali T.
    Spertus, John A.
    Solomon, Scott D.
    Tfelt-Hansen, Jacob
    van Sinttruije, Marion
    Veselka, Josef
    Watkins, Hugh C.
    Jacoby, Daniel L.
    Heitner, Stephen B.
    Kupfer, Stuart
    Malik, Fady I.
    Meng, Lisa
    Wohltman, Amy
    Olivotto, Iacopo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (19) : 1821 - 1831
  • [8] Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
    Maron, Martin S.
    Masri, Ahmad
    Choudhury, Lubna
    Olivotto, Iacopo
    Saberi, Sara
    Wang, Andrew
    Garcia-Pavia, Pablo
    Lakdawala, Neal K.
    Nagueh, Sherif F.
    Rader, Florian
    Tower-Rader, Albree
    Turer, Aslan T.
    Coats, Caroline
    Fifer, Michael A.
    Owens, Anjali
    Solomon, Scott D.
    Watkins, Hugh
    Barriales-Villa, Roberto
    Kramer, Christopher M.
    Wong, Timothy C.
    Paige, Sharon L.
    Heitner, Stephen B.
    Kupfer, Stuart
    Malik, Fady I.
    Meng, Lisa
    Wohltman, Amy
    Abraham, Theodore
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (01) : 34 - 45
  • [9] Aficamten in patients with obstructive hypertrophic cardiomyopathy: an integrated safety analysis
    Masri, A.
    Barriales-Villa, R.
    Elliott, P.
    Nassif, M. E.
    Owens, A. T.
    Oreziak, A.
    Tower-Rader, A.
    Chiu, M.
    Heitner, S. B.
    Kupfer, S.
    Malik, F., I
    Melloni, C.
    Meng, L.
    Wohltman, A.
    Saberi, S.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [10] Aficamten in non-obstructive hypertrophic cardiomyopathy: Unlocking new horizons?
    Rossi, Maddalena
    Fabris, Enrico
    Sinagra, Gianfranco
    EUROPEAN JOURNAL OF HEART FAILURE, 2024,
12345